| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 01/18/2006 | EP1470138B1 Mmp inhibitors |
| 01/18/2006 | EP1463799A4 Methods for the induction of professional and cytokine-producing regulatory cells |
| 01/18/2006 | EP1435951B1 Phenyl substituted 5-membered nitrogen containing heterocycles for the tretment of obesity |
| 01/18/2006 | EP1412338B1 1,3,5-triazine-2,4,6-triones, preparation and use as gonadotropin-releasing hormone receptor antagonists |
| 01/18/2006 | EP1404672B1 Tyrosine kinase inhibitors |
| 01/18/2006 | EP1404347B1 4'-substituded nucleosides for the treatment of diseases mediated by the hepatitis c virus |
| 01/18/2006 | EP1392309A4 Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor ligands |
| 01/18/2006 | EP1318761A4 Concurrent tooth repositioning and substance delivery |
| 01/18/2006 | EP1220852B1 Substituted diazepans |
| 01/18/2006 | EP0819004A4 Pharmaceutical composition containing proton pump inhibitors |
| 01/18/2006 | CN1723208A Magnesium salt of imidazole derivative |
| 01/18/2006 | CN1723196A Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
| 01/18/2006 | CN1723035A Use of ghrelin for treating malnutrition in gastrectomised individuals |
| 01/18/2006 | CN1723021A Stable solid medicinal composition for oral administration. |
| 01/18/2006 | CN1723014A Agent for dissolving dental calculi and dental caries |
| 01/18/2006 | CN1722959A Methods of using a beverage composition |
| 01/18/2006 | CN1721807A Reutilization method and apparatus for activatory furnace exhaust gas |
| 01/18/2006 | CN1721441A Novel hepatic factor of human embryo |
| 01/18/2006 | CN1721432A Peptide specifically associated with front surface antigen zone of large protein of human hepatitis B virus surface antigen and uses thereof |
| 01/18/2006 | CN1721412A 7-oxo pyridopyrimidines |
| 01/18/2006 | CN1720987A Medicine for warming kidney, strengthening yang, dredging liver and activating channels and its preparation process |
| 01/18/2006 | CN1720983A Preparation with asiabell, lotus seed pulp and licorice |
| 01/18/2006 | CN1720974A Chinese medicinal composition for treating ascites due to cirrhosis |
| 01/18/2006 | CN1720971A Stomatocace powder |
| 01/18/2006 | CN1720965A Chinese medicinal composition for treating acute icterohepatitis |
| 01/18/2006 | CN1720964A Stomachache easing dripping pills with celandine as raw materials and its preparation process |
| 01/18/2006 | CN1720927A Chinese traditional medicine for tonifying liver and kidney |
| 01/18/2006 | CN1720924A Application of montmorillonite in pharmacy |
| 01/18/2006 | CN1720919A Mesalazine controlled release oral pharmaceutical compositions |
| 01/18/2006 | CN1237073C Gene configuration, preparing process and usage of antibacterial peptide |
| 01/18/2006 | CN1237062C Ortho-substituted anthranilic acid amides and their use as medicaments |
| 01/18/2006 | CN1237061C Chemokine receptor binding heterocyclic compounds |
| 01/18/2006 | CN1236817C Novel mixtures of microbial enzymes |
| 01/18/2006 | CN1236811C Medicine for treating gastropathy |
| 01/18/2006 | CN1236810C Gastritis treating Chinese medicine |
| 01/18/2006 | CN1236808C Medicine for treating hepatitis B |
| 01/18/2006 | CN1236806C Liver-tonifying stone-removing Chinese medicine |
| 01/18/2006 | CN1236802C Medicine for treating gastritis and gastric ulcer |
| 01/18/2006 | CN1236799C Stomach disease treating medicine and its preparation method |
| 01/18/2006 | CN1236791C Chinese medicine positioning preparation for treating ulcerative colitis |
| 01/18/2006 | CN1236781C Compound stomach-ache treating capsule |
| 01/18/2006 | CN1236780C Animal cephalin capsule |
| 01/18/2006 | CN1236779C Use of mica in preparation of medicine |
| 01/18/2006 | CN1236772C Specific medicinal composition for treating hepatitis B |
| 01/18/2006 | CN1236770C Gastric acid secretion inhibiting composition |
| 01/18/2006 | CN1236769C Inhibitor for inhibiting cell adhesion |
| 01/18/2006 | CN1236763C Use of an epoxy-sterodal aldosterone antagonist for the treatment or prophylaxis of aldosterone-mediated pathogenic effects |
| 01/18/2006 | CN1236754C Systems for delivering a cosmetic and/or therapeutic active to oral surfaces using an integral carrier |
| 01/17/2006 | US6987184 Isothiazoloanthrones, isoxazoloanthrones, isoindolanthrones and derivatives thereof as JNK inhibitors and compositions and methods related |
| 01/17/2006 | US6987168 Tryptase inhibitor proteins derived from blood-feeding anthropod ectoparasites |
| 01/17/2006 | US6987128 Compounds of the N-acylamino amide family, compositions comprising same, and uses |
| 01/17/2006 | US6987123 A substituted pyrrole-1-yl-alkyloxy-aryl-2-alkyloxypropanoate derivatives, antilipiemic agents, anticholesterol agents |
| 01/17/2006 | US6987121 Compositions and methods for hepatoprotection and treatment of cholestasis |
| 01/17/2006 | US6987120 Pharmaceutical compounds |
| 01/17/2006 | US6987107 Method of treating incontinence |
| 01/17/2006 | US6987106 Nootropic agents; Alzheimer's Disease, Schizophrenia; ligands for the a7 subunits of the nicotinic receptor; 4-Bromophenyl-1,4-diazabicyclo[3.2.2]nonane-4-carboxylate |
| 01/17/2006 | US6987098 Health supplement |
| 01/17/2006 | US6987095 Fish feed with increased nucleotide content |
| 01/17/2006 | US6987005 Where the human SNORF33 receptor has the amino acid sequence SEQ ID NO: 6; encoded by ATCC deposited plasmids; activated by either tyramine, tryptamine, or beta -phenyl-ethylamine; vectors; cells; membranes; nervous system disorders |
| 01/17/2006 | CA2338792C Rapidly disintegrable solid preparation |
| 01/17/2006 | CA2334713C Therapeutic biaryl derivatives |
| 01/17/2006 | CA2286753C Solid pharmaceutical preparation |
| 01/12/2006 | US20060009528 Cannabinoid receptor ligands |
| 01/12/2006 | US20060009527 Method of treating TRX mediated diseases |
| 01/12/2006 | US20060009526 Method of treating TRX mediated diseases |
| 01/12/2006 | US20060009482 Screening method for identifying compounds that selectively induce interferon alpha |
| 01/12/2006 | US20060009464 4-(3-Phenyl-3-carbocycloylpropyl)-1-phenyl- or pyridylpiperazine derivatives: 1-(2-methoxyphenyl)-4-[3-(benzoyl)-3-(phenyl)propyl]piperazine oxalate; serotonin receptor antagonists; Alzheimer's disease |
| 01/12/2006 | US20060009409 Double-stranded oligonucleotides |
| 01/12/2006 | US20060009402 Engineered RNA precursors encoded in plasmids and/or other vectors; simple, low cost technique utilizing DNA molecule production; host cells, transgenes |
| 01/12/2006 | US20060008574 Galactosyl isomalt, method for production and use thereof |
| 01/12/2006 | US20060008471 Organ, tissue and cell-specific immuno-therapeutic for chronic viral infections and inflammatory, degenerative and proliferative diseases, in particular of the liver, and for cancer, based on a recombinant parapox virus |
| 01/12/2006 | DE202005014544U1 Healing dog-snack, useful for normalizing dogs during diarrhea and as fodder, comprises natural ingredients, where the snack is prepared by extrusion |
| 01/12/2006 | DE202004019097U1 Solid or liquid composition, useful e.g. to promote and/or support digestive- and liver activity and prevent and/or treat digestive complaints, comprises artichoke ingredients in combination with pineapple and/or papaya ingredients |
| 01/12/2006 | DE19961182B4 Galactomannan-Oligosaccharide und Verfahren zu deren Herstellung sowie deren Verwendung Galactomannan oligosaccharides and processes for their preparation and their use |
| 01/12/2006 | DE102004030504A1 Multi-particulate formulation, useful to generate a pH-value dependent active substance release in treating inflammatory intestinal diseases, comprises encapsulated medicine and/or natural substances |
| 01/12/2006 | CA2628005A1 Oral antimicrobial pharmaceutical compositions |
| 01/12/2006 | CA2572990A1 Use of substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines in the treatment of nausea and vomiting |
| 01/12/2006 | CA2572874A1 Urea derivative |
| 01/12/2006 | CA2569856A1 Prebiotic preparation |
| 01/12/2006 | CA2569530A1 Thienopyrazole derivative having pde 7 inhibitory activity |
| 01/11/2006 | EP1614688A1 Phenylazole compound, production process, and antioxidant drug |
| 01/11/2006 | EP1614684A1 Diamine derivative, production process, and antioxidizing drug |
| 01/11/2006 | EP1614678A2 Sulfur substituted sulfonylaminocarboxylic acid N-heteroarylamides, their preparation, their use and pharmaceutical preparations comprising them |
| 01/11/2006 | EP1614675A2 Amino acids with affinity for the alpha-2-delta protein |
| 01/11/2006 | EP1614431A2 Compositions for treatment of disorders of the oesophagus |
| 01/11/2006 | EP1613626A1 Cyclic benzimidazoles |
| 01/11/2006 | EP1613597A1 6-substituted nicotinamide derivatives as opioid receptor antagonists |
| 01/11/2006 | EP1613588A2 2-propylidene-19-nor-vitamin d compounds |
| 01/11/2006 | EP1613331A1 Compositions containing lactulose for treating rotavirus infections |
| 01/11/2006 | EP1613330A1 Combination of a macrolide t-cell immunomodulator and a calciferol for the treatment of skin diseases or of inflammatory bowel disease |
| 01/11/2006 | EP1469743A4 Stable hygroscopic compositions and methods for stabilizing hygroscopic ingredients |
| 01/11/2006 | EP1421082B1 piperidinyl-morpholinyl derivatives as modulators of chemokine receptor activity |
| 01/11/2006 | EP1407033B1 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (mva) |
| 01/11/2006 | EP1399130A4 Emulsion and dispersion formulations and method |
| 01/11/2006 | EP1395572B1 Process for preparing a thiazole ppar-ligand and polymorphs thereof |
| 01/11/2006 | EP1358169B1 Diaminothiazoles and their use as inhibitors of cyclin-dependent kinase |
| 01/11/2006 | EP1296670B1 Therapeutic combinations of fatty acids |
| 01/11/2006 | EP1294924B1 Competitive assay for identifying allosteric inhibitors |
| 01/11/2006 | EP1131310B1 Chrystals of 5- 6-(2-fluorobenzyl)oxy-2-naphthyl methyl]-2,4-thiazolidinedione |
| 01/11/2006 | EP1037632B1 Benzothiazole protein tyrosine kinase inhibitors |